JAMP FEBUXOSTAT
JAMP FEBUXOSTAT
Approved
DIN Number
02490870
Drug Class
Human
Market Date
Feb 25, 2020
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02490870
AIG Number0152809001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M04AA03 FEBUXOSTAT
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification92:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
FEBUXOSTATActive
Strength: 80 MG
Monograph: FEBUXOSTAT